Vehicle Flips on Route 31, Driver Charged With Driving Under the Influence

Vehicle flips on Route 31, driver charged with driving under the influence

Filed under: drug treatment centers in massachusetts

Clinton first aid and rescue squad transported Cook to Hunterdon Medical Center for further treatment and assessment of his injuries. Witnesses described Cook's vehicle as operating erratically and tailgating prior to losing control, hydroplaning and …
Read more on New Jersey Hills


CU Researchers Find Cure For Type 1 Diabetes In Mice

Filed under: drug treatment centers in massachusetts

BCG was tested at the Barbara Davis Childhood Diabetes Center in the late 80s. It did not work and Dr. Faustman … The ONLY difference I can see in your treatment vs Faustmans is the T1 will be bound to endless treatments with your newly developed …
Read more on CBS Local


A year of change, month by month

Filed under: drug treatment centers in massachusetts

Harvard celebrates the grand opening of the Massachusetts Green High Power Computing Center, a collaborative project with four leading research universities, the Commonwealth of Massachusetts, Cisco, and EMC to build a super-efficient green computing …
Read more on Harvard Gazette


MassDevice Big 100 East: News makers & Game changers
Event on 2013-07-16 16:00:00

News Makers. Game Changers

On July 16th, MassDevice  takes you inside the corner office for a front row seat on how decisions are made at the highest level of the medical device industry. 
We're pleased to welcome an incredible panel of leaders for our 2013 MassDevice Big 100 East and a look inside some of the companies, which have made headlines over the past two years.

This year, we welcome an extraordinary panel of executives, each of whom have changed the complexion of the medical device industry in some way.

The 6 CEOs represented have orchestrated the 3 largest M&A deals in med tech over the past two years, netted the single largest funding round in 2012 and are developing groundbreaking technology across all spectrum of the device world. 

The MassDevice Big 100 is a conversation among leaders–an unforgettable exchange of insight, ideas and contacts with the most prominent pioneers in our field.

*A limited number of rooms are available on a 'first come, first served' basis at the Westin Waltham on July 16th at the rate of 9.  After June 14, any available rooms will be subject to prevailing rates.

   The News Makers- Our Featured Guests
Catherine Burzik, Former CEO Kinectic Concepts, Inc.
Ms. Burzik is a seasoned senior executive in the healthcare industry who has successfully led major medical device, diagnostic, diagnostic imaging and life sciences businesses.

Most recently she served as President, Chief Executive Officer and Director of Kinetic Concepts, Inc. a leading medical device company specializing in the fields of woundcare and regenerative medicine. KCI was taken private by Apax Partners in 2011 for .1B , in the largest leveraged buyout since the fall of Lehman Brothers.

During Burzik's tenure KCI’s stock price doubled. She led significant product innovation, global expansion as well as diversification into regenerative medicine through the .7B acquisition of LifeCell.

Burzik currently advises several venture capital-backed biotech companies in San Antonio and San Francisco. She is a member of Board of Directors of Becton Dickinson, as well as the San Antonio Branch of the Dallas Federal Reserve Board. Cathy serves as Chairman of the Board, VitaPath Genetics Inc.; Chairman of the Canisius College Board of Trustees; and is a member of the Board of Trustees of the Keck Graduate School of Applied Life Sciences. Previously, Cathy was a member of the Board of Directors of Allscripts, Inc., the Board of Directors of Bausch and Lomb, the Board of Directors of Cordis Corporation and the Board of Directors of the medical device industry trade association AdvaMed, where she chaired the Woundcare and Tissue Regeneration Sector. In 2012, Cathy founded the Catherine M. and Francis N. Burzik Foundation dedicated to furthering higher educational and the performing arts
  Karen Licitra, Worldwide Chairman, Global Medical Solutions Group, Johnson & Johnson
Karen Licitra is Worldwide Chairman, Global Medical Solutions Group within Johnson & Johnson’s Medical Device and Diagnostics segment.  She is responsible for setting the strategy and vision for a portfolio of healthcare companies including the Vision Care, Diabetes Care and Ortho Clinical Diagnostics (OCD) franchises, as well as Advanced Sterilization Products (ASP) and the Sedation business unit.  Karen also leads the MD&D center of excellence for regulatory affairs.  Prior to her current role, she was Company Group Chairman for Johnson & Johnson and Worldwide Franchise Chairman for Ethicon Endo-Surgery, Inc., and Johnson & Johnson Medical, Canada. 
Karen is known for creating innovative new growth platforms and has a wealth of domestic and global industry experience acquired during 28 years in sales, marketing, commercial and general management.   She serves on the Board of Directors of the Advanced Medical Technology Association (AdvaMed), a trade association focused on the medical technology industry, and is a member of the Board of Trustees for the St. Peter's Healthcare System.  Karen is also the Board Chair for the Campaign to End Obesity, a cause committed to advancing national policy and platforms to combat obesity.          
A native of New Jersey, Karen earned a bachelor of science degree in marketing from Rider College (now Rider University). –[if gte mso 9]> [endif]–>

–[if gte mso 9]> Normal 0 false false false EN-US X-NONE X-NONE [endif]–>–[if gte mso 9]> [endif]–>–[if gte mso 10]>
/* Style Definitions */
{mso-style-name:"Table Normal";
mso-padding-alt:0in 5.4pt 0in 5.4pt;
font-family:"Times New Roman","serif";}
The Game Changers- A panel of innovators

Our CEO panel features the heads of some of the most innovative companies in Massachusetts
Jeff Burbank, CEO and founder, NxStage MedicalNxStage’s Founder, Chief Executive Officer, Jeff Burbank has over 20 years of in-depth management experience with companies developing, marketing and manufacturing products for End Stage Renal Disease patients. He has led NxStage since its inception, guiding it through all of its developmental phases to the successful initiation and rapid growth of commercial activities, its initial public offering, and the acquisition of Medisystems.
Watch our recent Disruptors episode with Jeff

Richard Packer, CEO, ZOLLRichard Packer joined the ZOLL in 1992 and became President of ZOLL in 1996 During 1996, he served as Chief Financial Officer of the Company and acted as interim Vice President of North American Sales. From 1992 to 1995 he served as the Company's Vice President of Operations. Prior to 1992, he was Vice President of various functions at Whistler Corporation, a consumer electronics company. Mr. Packer holds an MBA from the Harvard Business School, as well as engineering degrees from Rensselaer Polytechnic Institute.    Read our 2010 interview with Rick    Amarpreet Sawhney, President, CEO, Ocular TherapeutixAmarpreet Sawhney is the President and CEO of Ocular Therapeutix, Inc., a company focused on unmet needs in ophthalmic surgical wound management and drug delivery.  Previously, he was Founder and CEO of Confluent Surgical (acquired by Covidien), a biosurgery company, the Chairman of MarketRx (acquired by Cognizant), a provider of pharmaceutical marketing and sales analytics and intelligence, technology founder of Focal, Inc. (acquired by Genzyme) and Access Closure Inc.  Dr. Sawhney’s innovations are the subject of over 100 issued and pending patents. 
Watch our recent Disruptors episode with Amar

Philipp Lang,  CEO, President, Chairman of the Board, ConforMIS 

Dr. Lang founded ConforMIS in 2004 and has served as Chairman of the Board since its founding. He has been Chief Executive Officer since January 2008. Dr. Lang's management experience includes positions as the Director of the Musculoskeletal Radiology and Distinguished Weissman Chair at Brigham and Women's Hospital in Boston and Associate Professor at Harvard Medical School. Dr. Lang is also the founder of Imaging Therapeutics, Inc.. He has previously served as a Member on the Board of Directors of ViOptix, Inc. Dr. Lang has an extensive background in the medical device industry and has provided strategic leadership as an inventor of more than 80 patents, pending or issued, in the U.S. and abroad. He has an MBA from the UCLA Anderson School of Management and an MD from Albert-Ludwigs University, Freiburg School of Medicine in Germany.
Watch our recent Disruptors episode with Philipp

Underwriting for the Big 100 provided by:


In Partnership with:










at Westin Hotel
70 Third Avenue
Waltham, United States